Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin-Reference-Cited by-同舟云学术

Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin

Published:2006-04 Issue:4 Volume:50 Page:1581-1585
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Sakoulas George¹,Alder Jeff²,Thauvin-Eliopoulos Claudie³,Moellering Robert C.³,Eliopoulos George M.³

Affiliation:

1. Division of Infectious Diseases, New York Medical College, and Westchester Medical Center, Valhalla, New York 10595

2. Cubist Pharmaceuticals, Lexington, Massachusetts

3. Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts

Abstract

ABSTRACT We studied vancomycin and daptomycin susceptibility in methicillin-resistant Staphylococcus aureus from patients exposed to vancomycin, glycopeptide-intermediate S. aureus , and S. aureus passaged in vancomycin-containing medium. A correlation between vancomycin and daptomycin heteroresistance was noted in some strains, suggesting that exposure of S. aureus to vancomycin may affect susceptibility to daptomycin.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.50.4.1581-1585.2006

Reference19 articles.

1. Bactericidal Activities of Two Daptomycin Regimens against Clinical Strains of Glycopeptide Intermediate-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococcus faecium , and Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

2. Daptomycin disrupts membrane potential in growing Staphylococcus aureus

3. Fridkin, S. K., J. Hageman, L. K. McDougal, J. Mohammed, W. R. Jarvis, T. M. Perl, and F. C. Tenover. 2003. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis.36:429-439.

4. Geisel, R., F. J. Schmitz, A. C. Fluit, and H. Labischinski. 2001. Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis.20:685-697.

5. Hancock, R. E. 2005. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect. Dis.5:209-218.

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of MRSA Infection: Where are We?;Current Medicinal Chemistry;2024-08

2. Daptomycin Use for Persistent Coagulase-Negative Staphylococcal Bacteremia in a Neonatal Intensive Care Unit;Antibiotics;2024-03-12

3. Daptomycin plus ceftaroline salvage therapy for persistent Staphylococcus epidermidis bacteremia;Clinical Case Reports;2024-02

4. Empyema necessitans caused by methicillin-resistant Staphylococcus aureus: a case report and literature review;BMC Infectious Diseases;2024-02-01

5. Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis;Microbiology Spectrum;2023-12-12